ARTICLE | Company News
SuperGen, Stehlin Foundation for Cancer Research deal
November 22, 1999 8:00 AM UTC
SUPG acquired exclusive worldwide rights to camptothecin compounds and other anticancer compounds discovered by the foundation. SUPG already holds exclusive worldwide rights from the foundation to rub...